ISPE Announces its 2024 ISPE Annual Meeting & Expo Keynote Speakers, Including Health Authorities and Industry Leaders Across the Globe

30 August, 2024

The 2024 Annual Meeting & Expo, ISPE’s largest event of the year, taking place 13 to 16 October in Orlando, Florida, USA, and virtually, has announced its keynote speakers.

ISPE has announced keynote speakers from leading pharmaceutical companies including Eli Lilly, Takeda, Spark Therapeutics, and Syneos Health and regulators from the US Food and Drug Administration (US FDA), European Medicines Agency (EMA), and Health Canada, for the 2024 ISPE Annual Meeting & Expo.

I look forward to joining this year’s conference to share how regulators are working together to build a global regulatory reliance capability to better enable industry quality management. This patient-centered approach means looking beyond industry GMP compliance, to quality management that helps reduce the risk of shortages and ensure the availability of needed medicines. Quality management requires updating and innovating throughout the life cycle to continuously improve products and processes. This results in more agile quality management, improved operational resilience for both regulators and industry, and increased reliability in the supply of needed medicines for patients.


Mullin will provide the opening keynote presentation entitled “Enabling More Agile Pharmaceutical Quality Management: Ensuring the Availability of Medicines for Patients,” taking place Monday, 14 October. 

Breakout sessions and panel discussions will focus on the following tracks:

Confirmed featured regulatory speakers:

Emer Cooke
Executive Director
EMA
Hugo Hamel, MSc, MBA
Manager, Biotherapeutic Quality Division
Health Canada
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research
CBER/FDA

Confirmed featured industry speakers:

Gunter Baumgartner
SVP Head of Global Engineering
Takeda Pharmaceuticals International AG
Jill Black
Validation and Information Technology Principal Auditor, Quality Assurance
CTI Clinical Trial and Consulting Services
Renetta Mosley
Sr. Liaison, Patient Advocacy & Industry Relations Central Area
Acadia
Chris Stevens
Chief Patient Supply Officer
Spark Therapeutics, Inc.
Syed Abbas Yar-Khan
Group Vice President, Global Parenteral Products and Devices
Eli Lilly and Company

The event will also feature the following ancillary events:

Learn More & Register